Cargando…
Ultrasound-assisted intrathecal injection of nusinersen in a patient with severe vertebral deformity: a case report
BACKGROUND: Spinal muscular atrophy (SMA) is a mostly autosomal recessive genetic disease characterized by progressive muscle weakness from anterior horn degeneration. Nusinersen has recently been approved as a disease-modifying drug for SMA that needs to be administered intrathecally. Its injection...
Autores principales: | Nagano, Takashi, Sakura, Shinichi, Imamachi, Noritaka, Saito, Yoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419389/ https://www.ncbi.nlm.nih.gov/pubmed/32783149 http://dx.doi.org/10.1186/s40981-020-00367-y |
Ejemplares similares
-
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
por: Nakao, Sayo, et al.
Publicado: (2020) -
Local anesthetic systemic toxicity of levobupivacaine in erector spinae plane block
por: Yawata, Shunsuke, et al.
Publicado: (2021) -
Effects of an intrathecal TRPV1 antagonist, SB366791, on morphine-induced itch, body temperature, and antinociception in mice
por: Sakakibara, Satoshi, et al.
Publicado: (2019) -
Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience
por: Haché, Manon, et al.
Publicado: (2016) -
Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis
por: Rosiak, Grzegorz, et al.
Publicado: (2021)